Home › Mga Sakit ng Endocrine › California
Pag-aaral pangklinika para sa Mga Sakit ng Endocrine sa California
6 pag-aaral para sa Mga Sakit ng Endocrine ang naghahanap ng mga kalahok sa mga site sa California.
Opisyal na teksto ng pag-aaral (English)
Trial Investigating the Efficacy and Safety of Weekly Lonapegsomatropin Compared to Daily Somatropin in Children and Adolescents With Short Stature or Growth Failure Due to Growth Hormone Sufficient Disorders
- Ascendis Pharma Investigational Site, Palo Alto
- Ascendis Pharma Investigational Site, Sacramento
Nagre-recruitPhase 3
Edad 2 hanggang 17 · Lahat ng kasarian · Na-update Nob 5, 2026 · NCT07221851A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
- San Fernando Valley Health Institute, Canoga Park
- Headlands Research California, LLC, Escondido
- ImmuniMet, LLC, Modesto
- at 4 pa
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 5, 2026 · NCT07595549Understanding New Cachexia Subtypes Through Observational Epidemiological Research
- Kaiser Permanente Northern California, Pleasanton
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 20, 2026 · NCT07776353Study of BHV-1300 in Graves' Disease
- Site-103, South Gate
Nagre-recruitPhase 1
Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Hul 31, 2026 · NCT06980649A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
- St Joseph Heritage Healthcare, Santa Rosa
Nagre-recruitPhase 1/2
Edad 12 pataas · Lahat ng kasarian · Na-update May 27, 2026 · NCT03093116Rising Tide - Amniotic Tissue(s) Treatments for Chronic Diabetic Foot Ulcers
- Limb Preservation Platform Inc, Fresno
- Angel City Research, Los Angeles
- Clemente Clinical Research, Los Angeles
- at 1 pa
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Peb 10, 2025 · NCT06681428Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.